News Focus
News Focus
icon url

scottsmith

10/10/18 8:00 PM

#244494 RE: Amatuer17 #244492

Ipix will never pay the cro. That is clear as day.
icon url

JTORENCE

10/10/18 9:44 PM

#244508 RE: Amatuer17 #244492

Amatuer17 care to read the PR again.

BEVERLY, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX), a clinical stage biopharmaceutical company, is pleased to report that it has secured new financing for up to $10 million from one multi-family office focused on healthcare and life sciences, including an initial net placement of approximately $2.2 million over the first 30 days. These funds will be used to continue to advance the Company’s pipeline of first-in-class drug candidates: Brilacidin for Oral Mucositis, Kevetrin for Ovarian Cancer and Prurisol for Psoriasis.